KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Gross Profit (2016 - 2025)

Biogen (BIIB) has 17 years of Gross Profit data on record, last reported at $1.8 billion in Q4 2025.

  • For Q4 2025, Gross Profit fell 4.67% year-over-year to $1.8 billion; the TTM value through Dec 2025 reached $7.5 billion, up 1.64%, while the annual FY2025 figure was $7.5 billion, 1.64% up from the prior year.
  • Gross Profit reached $1.8 billion in Q4 2025 per BIIB's latest filing, down from $1.9 billion in the prior quarter.
  • Across five years, Gross Profit topped out at $2.3 billion in Q2 2021 and bottomed at $1.6 billion in Q2 2022.
  • Average Gross Profit over 5 years is $2.0 billion, with a median of $1.9 billion recorded in 2024.
  • Peak YoY movement for Gross Profit: fell 29.76% in 2022, then grew 6.34% in 2025.
  • A 5-year view of Gross Profit shows it stood at $2.1 billion in 2021, then decreased by 4.85% to $2.0 billion in 2022, then decreased by 5.19% to $1.9 billion in 2023, then rose by 0.03% to $1.9 billion in 2024, then dropped by 4.67% to $1.8 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $1.8 billion in Q4 2025, $1.9 billion in Q3 2025, and $2.0 billion in Q2 2025.